These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5438397)

  • 21. The significance of vasodilator therapy in obliterative arterial disease.
    Thulesius O
    Scand J Clin Lab Invest Suppl; 1967; 99():222-4. PubMed ID: 6056925
    [No Abstract]   [Full Text] [Related]  

  • 22. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E; Martinelli M; Capitanucci P; De Gregorio M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
    [No Abstract]   [Full Text] [Related]  

  • 23. [Status and correction of regional lipid metabolism in atherosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Parakhoniak NV; Zubova TA
    Kardiologiia; 1987 Mar; 27(3):77-81. PubMed ID: 2438448
    [No Abstract]   [Full Text] [Related]  

  • 24. [PEPTIC ULCER AND PERIPHERAL OBSTRUCTIVE ARTERIOPATHY. CLINICO-STATISTICAL AND PHYSIOPATHOGENETIC FINDINGS].
    ALLORI L; PEREGO MA
    Rass Fisiopatol Clin Ter; 1963; 35():506-14. PubMed ID: 14091626
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
    Modica G; Ferrante R
    Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood lipid changes induced by chorionic gonadotropins in aged persons with arteriosclerosis].
    Salvioli GF; Neri M; Vecchi GP
    G Gerontol; 1971 Dec; 19(12):964-70. PubMed ID: 5147503
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].
    Dudaev VA; Gorin VV; Shingireĭ MV; Kliuchnikova ZhI; Diukov IV
    Kardiologiia; 1984 Jun; 24(6):76-9. PubMed ID: 6748497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intra-arterial infusion in the treatment of severe forms of occlusive vascular diseases of the lower limbs].
    Lytkin MI; Nazarov GD; Barinov VS
    Vestn Khir Im I I Grek; 1981 Jan; 126(1):78-82. PubMed ID: 7222426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacodynamic effect of chelating agents on the peripheral and renal circulation of persons with healthy blood vessels and with vascular diseases].
    Hackel F; Graubitz M
    Z Gesamte Inn Med; 1969 Nov; 24(21):761-6. PubMed ID: 4983476
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum lipids and lipoproteins in arteriosclerosis obliterans of the lower extremities.
    Berezovsky LA; de Wolfe VG; Lewis LA
    Medicina (B Aires); 1978; 38(6 Pt 1):652-8. PubMed ID: 750857
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lipids and hyperlipoproteinemia].
    Magnenat G
    Ther Umsch; 1970 Sep; 27(9):566-73. PubMed ID: 5508271
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood lipid composition in patients with obliterating atherosclerosis in lower extremities (author's transl)].
    Zapletalová J; Vinogradov S; Puchmayer V; Mares P; Skorepa J
    Cas Lek Cesk; 1979 Feb; 118(5):146-8. PubMed ID: 436141
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of adrenalectomy and lumbar ganglionectomy in the therapy of chronic peripheral obliterating arteriopathy (C.P.O.A.) of the lower extremities].
    Guagliano G; Vittori C; Maurizio A; Taborelli R
    Minerva Chir; 1967 Feb; 22(4):159-70. PubMed ID: 6050194
    [No Abstract]   [Full Text] [Related]  

  • 34. [BIOCHEMICAL EXPLORATION OF BLOOD LIPID DISORDERS ASSOCIATED WITH ATHEROSCLEROSIS].
    HEUSGHEM C; DALIMIER-BROUHON N
    Rev Med Liege; 1963 Aug; 18():507-19. PubMed ID: 14057997
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
    Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
    Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
    [No Abstract]   [Full Text] [Related]  

  • 36. [On some aspects of therapy of chronic peripheral obliterating arteriopathies (C.P.O.A.) on arteriosclerotic nature].
    Seghezzi R; Borri P; Pedroni G
    Minerva Med; 1968 Dec; 59(99):5458-65. PubMed ID: 5718833
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical, oscillographic and plethysmographic comparison before and after medical and surgical treatment of subjects with peripheral obliterating arteriopathy].
    Tardito E; Grassi T
    Minerva Med; 1971 May; 62(39):1971-80. PubMed ID: 5579735
    [No Abstract]   [Full Text] [Related]  

  • 38. [Extragonadal action of human gonadotropins].
    Consolo F
    Minerva Ginecol; 1968 Sep; 20(17):1448-9. PubMed ID: 5739903
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hematocrit value in patients with sclerotic obstructive arteriopathy].
    Meciani L; Parmeggiani A; Prestipino F; Ricci G; Boeri S
    Minerva Cardioangiol; 1968 Feb; 16(2):81-91. PubMed ID: 5736319
    [No Abstract]   [Full Text] [Related]  

  • 40. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.